Advertisement

Advertisement

AACR Virtual Annual Meeting 2020 II

Christopher I. Amos, PhD, Receives Award for Research Excellence in Cancer Epidemiology and Prevention

The American Association for Cancer Research (AACR) is honoring Christopher I. Amos, PhD, with the 2020 AACR–American Cancer Society (ACS) Award for Research Excellence in Cancer Epidemiology and Pre...

Charles L. Sawyers, MD, FAACR, Voted AACR Academy President-Elect for 2020–2021

The Fellows of the American Association for Cancer Research (AACR) Academy have chosen Charles L. Sawyers, MD, FAACR, as President-Elect for 2020–2021. Dr. Sawyers will assume the presidency during t...

Genomics/Genetics

Study Finds Young Adults With Cancer May Harbor Germline Mutations and Benefit From Germline Genetic Testing

According to the National Cancer Institute, each year, about 70,000 adolescents and young adults (AYAs)—those between the ages of 15 and39—are diagnosed with cancer.1 Evidence suggests that some cance...

AACR Recognizes New 2019–2020 Research Grantees

The American Association for Cancer Research (AACR) has announced its newest class of grant recipients. Fellowships The 2019 Anna D. Barker Fellowship in Basic Cancer Research was awarded to Chaoyun P...

Immunotherapy

Personalized RNA-Based Vaccine/Atezolizumab Combination Produced Immune Response in Most Patients With Advanced Tumors

AN APPROACH using an RNA-based personalized cancer vaccine called RO7198457 in combination with the PD-L1 inhibitor atezolizumab has shown a preliminary benefit, according to an early study in patient...

Issues in Oncology

Study Finds Significant Variation in Hispanic Patients’ Trust of Cancer Information Sources

A study by Camacho-Rivera et al published in Cancer Epidemiology, Biomarkers & Prevention examining how increasing knowledge about cancer and cancer services among Hispanic adults may help in redu...

Skin Cancer
Immunotherapy

Real-World Data Show Survival Benefit for Adjuvant Immunotherapy in Stage III Melanoma

Although ipilimumab is approved as adjuvant therapy for stage III melanoma and has been shown to improve survival when given after complete resection, a little more than one-third of eligible patients...

Immunotherapy

Personalized RNA-Based Vaccine/Atezolizumab Combination Produced Immune Response in Most Patients With Advanced Tumors

AN APPROACH using an RNA-based personalized cancer vaccine called RO7198457 in combination with the PD-L1 inhibitor atezolizumab has shown a preliminary benefit, according to an early study in patient...

Issues in Oncology

Underrepresentation of Black Patients in Cancer Clinical Trials: Public vs Pharmaceutical Sponsorship

Black patients are better represented in taxpayer-funded cancer clinical trials compared to trials run by pharmaceutical companies, although they remain underrepresented in clinical trials, regardless...

Gynecologic Cancers

Lipophilic Statins May Reduce Mortality in Patients With Ovarian Cancer

Lipophilic statins—a type of medication commonly prescribed to lower blood cholesterol—were associated with reduced mortality in patients with ovarian cancer, according to a study presented by Kala Vi...

Issues in Oncology
Hematologic Malignancies

Survival Disparities Seen in Hispanic Patients With Blood Cancers Living Near the United States/Mexico Border

A study by Bencomo-Alvarez et al investigating the incidence and survival for Hispanic patients with hematologic malignancies living along the United States/Mexico border in El Paso, Texas, has found ...

Genomics/Genetics
Solid Tumors

Young Adults With Cancer May Benefit From Germline Genetic Testing

According to the National Cancer Institute, each year, about 70,000 adolescents and young adults (AYA)—those between the ages of 15 and 39—are diagnosed with cancer. Evidence suggests that some cancer...

Advertisement

Advertisement



Advertisement